Alpharetta, United States
Mogram is a Health Care startup founded in 2019 and based in the United Kingdom. The company's slogan, "We fix the human error problem in mammogram reading. State-of-art solutions for radiologists and women," encapsulates its mission to address the issue of radiologists missing ~10% of breast cancer cases due to human error. By leveraging state-of-the-art artificial intelligence solutions, Mogram aims to eradicate this problem, ensuring that no case of breast cancer is overlooked.
The startup recently received a £1.10M Seed Round investment from Britbots on 16 January 2022, signifying confidence in its innovative approach to improving mammogram reading. Through its advanced technology, Mogram offers radiologists the tools to detect various pathologies, from mass detection to skin thickening, enhancing the accuracy and efficiency of mammogram evaluations.
Mogram represents a promising investment opportunity, addressing a critical need in the healthcare industry and demonstrating potential for substantial impact. The recent Seed Round investment from Britbots underscores the industry's recognition of Mogram's potential to revolutionize mammogram reading, underscoring its position as a forward-thinking and impactful player in the healthcare technology space.
